You are here

Hawaii Biotech, Inc.

Company Information
Address
650 Iwilei Rd Ste 204
Honolulu, HI 96817-5318
United States



Information

UEI: ECJKEEFL4L51

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. TAXOL PURIFICATION BY MONOCLONAL ANTIBODY IMMUNOADSORBENTS

    Amount: $500,000.00

    THIS PHASE I PROJECT IS DESIGNED TO TEST THE FEASIBILITY OF PURIFYING TAXOL BY IMMUNOAFFINITY CHROMATOGRAPHY. THE USE OF THIS TECHNIQUE FOR PURIFICATION OF A LOW MOLECULAR WEIGHT COMPOUND WITH LOW AQU ...

    SBIRPhase II1993Department of Health and Human Services
  2. Synthesis of a Taxol-Cehalosporin Prodrug

    Amount: $50,000.00

    A Taxol prodrug derivative will be prepared. This compound will be tested for its differential cytotoxicity compared to Taxol and for its ability to be enzymatically activated. The cytotoxicity of the ...

    SBIRPhase I1993Department of Health and Human Services
  3. CLONING AND STUDIES OF NEUROSPORA ALKALINE PROTEASE

    Amount: $50,000.00

    THE DEVELOPMENT OF MICROBIAL SYSTEMS FOR EXPRESSION OF HETEROLOGOUS PROTEINS HAS ENABLED THE ISOLATION OF GREATER AMOUNTS OF SOURCE PROTEINS, OFTEN IN GREATER PURITY THAN IS POSIBLE FROM THE ORIGINAL ...

    SBIRPhase I1993National Science Foundation
  4. Light-Regulated Heterologous Expression in Neurospora

    Amount: $50,000.00

    Regulation of gene expression is critical for cellular and organismal development, and it often plays an important role in expression of heterologous recombinant proteins. Toward development of regula ...

    SBIRPhase I1993Department of Health and Human Services
  5. Expression of Single-chain FV in Neurospora Crassa

    Amount: $50,000.00

    The filamentous fungi, owing to their ability to secrete high levels of proteins, are attractive organisms for the expression and secretion of heterologous proteins of commercial and medical value. Se ...

    SBIRPhase I1993Department of Health and Human Services
  6. DEVELOPMENT OF POLYCLONAL SERA AND MONOCLONAL HYBRIDOMAS TO WILD TYPE MEASLES VIRUS ANTIGENS

    Amount: $50,000.00

    N/A

    SBIRPhase I1993Department of Health and Human Services
  7. PALYTOXIN PRODRUG ACTIVATION BY ANTIBODY-LINKED ENZYME

    Amount: $459,212.00

    PALYTOXIN IS AN EXTREMELY CYTOTOXIC LOW MOLECULAR WEIGHT NATURAL PRODUCT ISOLATED FROM SOFT CORALS OF THE GENUS, PALYTHOA. N-ACYLATED DERIVATIVES OF PALYTOXIN HAVE BEEN REPORTED TO BE UP TO 100-FOLD L ...

    SBIRPhase II1992Department of Health and Human Services
  8. UREASE-LINED IMMUNOASSAY REAGENT STABILITY STUDIES

    Amount: $901,147.00

    UREASE OFFERS DISTINCT ADVANTAGES OVER OTHER ENZYMES FOR PREPARATION OF CONJUGATES USED IN ENZYME-LINKED IMMUNO-SORBENT ASSAY SYSTEMS. MOLECULAR DEVICES CORPORATION (MENLO PARK, CA) HAS CAPITALIZED ON ...

    SBIRPhase II1992Department of Defense Army
  9. NEUROSPORA SECRETION EXPRESSION VECTOR DEVELOPMENT

    Amount: $50,000.00

    PRODUCTION OF RECOMBINANT PRODUCTS OF PHARMACEUTICAL AND INDUSTRIAL IMPORTANCE IN A VARIETY OF MICROORGANISMS HAS YIELDED A WIDE VARIETY OF BIOLOGICALLY ACTIVE PROTEINS. FUNGI OFFER THE ADVANTAGE OF R ...

    SBIRPhase I1992National Science Foundation
  10. FUNGAL EXPRESSION OF DENGUE PROTEINS FOR VACCINES

    Amount: $50,000.00

    DENGUE VIRUSES ARE A LEADING CAUSE OF MORBIDITY THROUGHOUT THE TROPICS AND SUBTROPICS. ATTEMPTS TO DEVELOP LIVE ATTENUATED DENGUE VACCINES ANALOGOUS TO THE YELLOW FEVER VACINE HAVE BEEN UNSUCCESSFUL. ...

    SBIRPhase I1992Department of Health and Human Services
US Flag An Official Website of the United States Government